Centre Hospitalier Universitaire De Montpellier

At Centre Hospitalier Universitaire De Montpellier, clinical trials in Digestive System Diseases focus strongly on hepatology, liver transplantation, and gastroenterology. The studies are centered on conditions such as hepatocellular carcinoma, cholangiocarcinoma, inflammatory liver adenomas, and transplant-related care, with the goal of improving treatment effectiveness, supporting long-term transplant outcomes, and evaluating new therapeutic strategies.

• Research on hepatocellular carcinoma and cholangiocarcinoma is assessing whether new cancer treatments can improve survival and disease control.
• Liver transplantation studies are examining better ways to maintain graft function and reduce treatment failure after transplant.
• Trials in inflammatory liver conditions are exploring targeted approaches to shrink lesions and improve clinical management.

This field reflects a broad effort to advance care for complex liver diseases and related digestive disorders through more effective and better-tolerated treatment options.

A major part of the research portfolio at this site involves Neoplasms and Hemic and Lymphatic Diseases. Trials are studying lymphoma, acute myeloid leukemia, bladder cancer, melanoma, and other advanced cancers, with a focus on improving survival, preventing recurrence, and refining cancer immunotherapy and targeted treatment combinations.

• Diffuse large B-cell lymphoma, follicular lymphoma, and marginal zone lymphoma studies are evaluating new treatment combinations for relapsed or newly diagnosed disease.
• Acute myeloid leukemia research includes treatment strategies around transplantation and long-term outcomes.
• Trials in melanoma and bladder cancer are testing perioperative and adjuvant approaches to reduce recurrence risk.

These studies highlight the site’s active role in developing more precise and effective cancer therapies, especially for difficult-to-treat blood cancers and solid tumors.

The site also conducts trials in Immune System Diseases and Skin and Connective Tissue Diseases, including atopic dermatitis and hidradenitis suppurativa. The research is aimed at improving symptom control, maintaining remission, and testing newer immune-targeted treatments for chronic inflammatory conditions.

• Atopic dermatitis studies are looking at whether treatment can be safely adjusted while preserving long-term disease control.
• Hidradenitis suppurativa research is evaluating therapies designed to reduce inflammation and improve skin disease severity.
• These trials support better management of chronic immune-driven disorders that can significantly affect quality of life.

The Hépato-Gastroentérologie et Transplantation A department contributes to research that links inflammatory disease control with practical, patient-centered treatment goals.

Clinical studies in Nervous System Diseases, Nutritional and Metabolic Diseases, and Genetic Phenomena include Alzheimer’s disease, multiple sclerosis, narcolepsy, sickle cell disease, and rare genetic syndromes. The purpose of this work is to evaluate whether new therapies can improve symptoms, reduce relapse or disease activity, and offer better long-term control for patients with complex conditions.

• Alzheimer’s disease and mild cognitive impairment trials are focused on slowing decline and measuring changes in cognition.
• Multiple sclerosis research is comparing treatment options to maintain disease stability over time.
• Narcolepsy, sickle cell disease, and rare genetic disorder studies are assessing symptom relief, safety, and broader clinical benefit.

This diverse portfolio shows a strong interest in both common neurological disorders and less frequent inherited or systemic diseases.

Trials in Virus Diseases at Centre Hospitalier Universitaire De Montpellier include vaccine and prevention studies for human papillomavirus and yellow fever, as well as broader immune-response research. These studies aim to improve protection against infection and evaluate whether vaccines can generate strong and lasting immune responses.

• HPV prevention research is focused on reducing persistent oral infection linked to high-risk viral types.
• Yellow fever vaccine studies are assessing immune response and protection in adults.
• Additional work explores how vaccines may strengthen preventive care in populations at risk of viral disease.

This area reflects the site’s contribution to public health research through prevention-focused trials and immune protection studies.

A distinctive feature of the clinical research program is the emphasis on transplantation and long-term follow-up after advanced therapies. These studies examine how to optimize immunosuppression, monitor safety over time, and understand outcomes after innovative cell-based or transplant-related treatments.

• Research is evaluating better strategies for maintaining stability after liver transplantation.
• Long-term follow-up studies are tracking safety and durability after gene-modified T cell therapy.
• These trials aim to improve ongoing care for patients who have already received complex therapies.

The site’s transplant-focused expertise supports research that looks beyond immediate treatment response to long-term patient safety and durability of benefit.